(2R,3S,5S)-3-(Benzyloxy)-5-[6-(benzyloxy)-2-{[(4-methoxyphenyl)(diphenyl)methyl]amino}-9H-purin-9-yl]-2-[(benzyloxy)methyl]cyclopentanone(CAS: 142217-79-6)

This compound is a crystalline solid with a high molecular weight, exhibiting low solubility in water but good solubility in organic solvents. It displays low reactivity under normal conditions, but can undergo hydrolysis under acidic or basic conditions. Its physical and chemical stability make it suitable for use in pharmaceutical and bioanalytical applications.

This compound can be synthesized via a multi-step process involving the protection of a purine ring with a benzyl group, followed by alkylation, amide formation, and subsequent deprotection. Common catalysts include triphenylphosphine and other Lewis bases, with yields typically ranging from 50-70%.

This compound is primarily used in the pharmaceutical industry for the development of novel therapeutic agents, particularly in the treatment of diseases such as cancer and viral infections. It is also explored in biotechnology and materials science for applications in sensors and semiconductors.

When handling this compound, it is essential to wear appropriate personal protective equipment (PPE), including gloves, safety goggles, and a lab coat. Work should be conducted in a well-ventilated area or fume hood. In the event of a spill, immediately clean up with appropriate absorbent materials and ensure proper disposal. Always refer to the Safety Data Sheet (SDS) for detailed information on handling and storage.